Biological Basis of Addiction and Alcohol Use Disorder

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2024 Jun 4

PMID 38831763

Authors

Ryan E Tyler

Lorenzo Leggio

Affiliations

Soon will be listed here.

References

Morrow A, Boero G, Porcu P . A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies. Alcohol Clin Exp Res. 2019; 44(2):320-339. PMC: 7018555. DOI: 10.1111/acer.14253. View

Lovelock D, Tyler R, Besheer J . Interoception and alcohol: Mechanisms, networks, and implications. Neuropharmacology. 2021; 200:108807. PMC: 8541934. DOI: 10.1016/j.neuropharm.2021.108807. View

Volkow N, Swanson J . Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry. 2003; 160(11):1909-18. DOI: 10.1176/appi.ajp.160.11.1909. View

Lovinger D, White G, Weight F . Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 1989; 243(4899):1721-4. DOI: 10.1126/science.2467382. View

Uhl G, Koob G, Cable J . The neurobiology of addiction. Ann N Y Acad Sci. 2019; 1451(1):5-28. PMC: 6767400. DOI: 10.1111/nyas.13989. View

Farokhnia M, Faulkner M, Piacentino D, Lee M, Leggio L . Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder. Physiol Behav. 2019; 204:49-57. DOI: 10.1016/j.physbeh.2019.02.008. View

Klausen M, Thomsen M, Wortwein G, Fink-Jensen A . The role of glucagon-like peptide 1 (GLP-1) in addictive disorders. Br J Pharmacol. 2021; 179(4):625-641. PMC: 8820218. DOI: 10.1111/bph.15677. View

Flippo K, Trammell S, Gillum M, Aklan I, Perez M, Yavuz Y . FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit. Cell Metab. 2022; 34(2):317-328.e6. PMC: 9093612. DOI: 10.1016/j.cmet.2021.12.024. View

Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren L . Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 2021; 46(10):1715-1723. PMC: 8357831. DOI: 10.1038/s41386-020-00950-y. View

10.

Lehner T, Gao B, Mackowiak B . Alcohol metabolism in alcohol use disorder: a potential therapeutic target. Alcohol Alcohol. 2023; 59(1). PMC: 10783952. DOI: 10.1093/alcalc/agad077. View

11.

Molina P, Nelson S . Binge Drinking's Effects on the Body. Alcohol Res. 2018; 39(1):99-109. PMC: 6104963. View

12.

Leggio L, Mellinger J . Alcohol use disorder in community management of chronic liver diseases. Hepatology. 2022; 77(3):1006-1021. DOI: 10.1002/hep.32531. View

13.

Schuckit M . Alcohol sensitivity and dependence. EXS. 1994; 71:341-8. DOI: 10.1007/978-3-0348-7330-7_34. View

14.

Crews F, Lawrimore C, Jordan Walter T, Coleman Jr L . The role of neuroimmune signaling in alcoholism. Neuropharmacology. 2017; 122:56-73. PMC: 5493978. DOI: 10.1016/j.neuropharm.2017.01.031. View

15.

Volkow N, Boyle M . Neuroscience of Addiction: Relevance to Prevention and Treatment. Am J Psychiatry. 2018; 175(8):729-740. DOI: 10.1176/appi.ajp.2018.17101174. View

16.

Koob G, Volkow N . Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016; 3(8):760-773. PMC: 6135092. DOI: 10.1016/S2215-0366(16)00104-8. View